Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-18,820
Closed -$4.15M 93
2025
Q2
$4.15M Buy
+18,820
New +$3.39M 0.01% 600
2021
Q3
Sell
-5,900
Closed -$282K 1222
2021
Q2
$282K Buy
+5,900
New +$294K ﹤0.01% 1178
2017
Q3
Sell
-27,500
Closed -$1.65M 1308
2017
Q2
$1.65M Sell
27,500
-400
-1% -$25.8K 0.01% 823
2017
Q1
$1.85M Buy
+27,900
New +$1.95M 0.01% 797
2014
Q1
Sell
-4,100
Closed -$113K 1395
2013
Q4
$113K Buy
+4,100
New +$95.9K ﹤0.01% 1271

Other funds holding AGX

Axa's AGX Position: Q3 2025 in Review

Axa sold out of Argan (AGX) in Q3 2025, closing a stake of 18,820 shares — an estimated $4.15M sold.

Axa first reported a position in AGX in Q4 2013 and held it in 5 quarters. The position peaked at $4.15M in Q2 2025. 390 funds tracked by Wall St. Rank hold AGX as of Q3 2025.

  • Axa reported no remaining Argan position as of Q3 2025 after selling out during the quarter.
  • Axa sold 18,820 Argan shares in Q3 2025, an estimated $4.15M.
  • Axa first reported a position in Argan in Q4 2013 and held it in 5 quarters.
  • Axa's Argan position peaked at $4.15M in Q2 2025.
  • 390 funds tracked by Wall St. Rank held Argan as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.